EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Randomisierte kontrollierte StudieOpen Access

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis

Javier Bolaños-Meade, Mehdi Hamadani, Juan Wu, Monzr M Al Malki, Michael J Martens iD, Lyndsey Runaas, Hany Elmariah, Andrew R Rezvani, Mahasweta Gooptu, Karilyn T Larkin, Brian C Shaffer, Najla El Jurdi und 19 weitere

New England Journal of Medicine · 22.06.2023 · 388 (25) · 2338-2348

DOI: 10.1056/nejmoa2215943 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 22.06.2023. Verfasst von Javier Bolaños-Meade und 30 weiteren Autor:innen. Beteiligte Einrichtung: From the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, and the Department of Oncology, Johns Hopkins University School of Me…. Hauptthemen laut MEDLINE: Bronchiolitis Obliterans Syndrome, Cyclophosphamide, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 643-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchiolitis Obliterans SyndromeCyclophosphamideGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHematologic NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsAdultHumansMethotrexateMycophenolic AcidNeoplasm Recurrence, LocalTacrolimusUnrelated Donors

Substanzen

CyclophosphamideMethotrexateMycophenolic AcidTacrolimus

Autor:innen und Institutionen

  • From the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, and the Department of Oncology, Johns Hopkins University School of Medicine, Baltimore (J.B.-M., R.J.J.), Emmes, Rockville (J.W., K.A.), an…

ORCID-Profile: Michael J Martens, Omer H Jamy, Ami S Bhatt, Ran Reshef, Eric Leifer

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Cancer Institute

Zitieren

APA

Bolaños-Meade, J., Hamadani, M., Wu, J., Al Malki, M. M., Martens, M. J., Runaas, L., Elmariah, H., Rezvani, A. R., Gooptu, M., Larkin, K. T., Shaffer, B. C., El Jurdi, N., Loren, A. W., Solh, M., Hall, A. C., Alousi, A. M., Jamy, O. H., Perales, M. A., Yao, J. M., …, & BMT CTN 1703 Investigators (2023). Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis. New England Journal of Medicine, 388(25), 2338-2348. https://doi.org/10.1056/nejmoa2215943

Vancouver

Bolaños-Meade J, Hamadani M, Wu J, Al Malki MM, Martens MJ, Runaas L, et al. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis. New England Journal of Medicine. 2023;388(25):2338-2348. doi:10.1056/nejmoa2215943

BibTeX
@article{BolaosMeade2023,
  author = {Bolaños-Meade, Javier and Hamadani, Mehdi and Wu, Juan and Al Malki, Monzr M and Martens, Michael J and Runaas, Lyndsey and Elmariah, Hany and Rezvani, Andrew R and Gooptu, Mahasweta and Larkin, Karilyn T and Shaffer, Brian C and El Jurdi, Najla and Loren, Alison W and Solh, Melhem and Hall, Aric C and Alousi, Amin M and Jamy, Omer H and Perales, Miguel-Angel and Yao, Janny M and Applegate, Kristy and Bhatt, Ami S and Kean, Leslie S and Efebera, Yvonne A and Reshef, Ran and Clark, William and DiFronzo, Nancy L and Leifer, Eric and Horowitz, Mary M and Jones, Richard J and Holtan, Shernan G and BMT CTN 1703 Investigators, BMT CTN 1703 Investigators},
  title = {Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {388},
  number = {25},
  pages = {2338--2348},
  doi = {10.1056/nejmoa2215943}
}
Kostenlos starten →